These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Alpha-tocopherol supplementation of macrophages does not influence their ability to oxidize LDL. Baoutina A; Dean RT; Jessup W J Lipid Res; 1998 Jan; 39(1):114-30. PubMed ID: 9469591 [TBL] [Abstract][Full Text] [Related]
3. Oxidation of low density lipoproteins leads to disturbance of their binding with alpha-tocopherol. Bakalova RA; Goudev AR; Zhelev ZZ; Nachev C; Ribarov SR Gen Physiol Biophys; 1996 Dec; 15(6):463-75. PubMed ID: 9248832 [TBL] [Abstract][Full Text] [Related]
4. Physiologic levels of ascorbate inhibit the oxidative modification of low density lipoprotein. Jialal I; Vega GL; Grundy SM Atherosclerosis; 1990 Jun; 82(3):185-91. PubMed ID: 2375783 [TBL] [Abstract][Full Text] [Related]
5. Flavonoids inhibit the oxidative modification of low density lipoproteins by macrophages. de Whalley CV; Rankin SM; Hoult JR; Jessup W; Leake DS Biochem Pharmacol; 1990 Jun; 39(11):1743-50. PubMed ID: 2344371 [TBL] [Abstract][Full Text] [Related]
6. The role of copper reduction by alpha-tocopherol in low-density lipoprotein oxidation. Proudfoot JM; Croft KD; Puddey IB; Beilin LJ Free Radic Biol Med; 1997; 23(5):720-8. PubMed ID: 9296448 [TBL] [Abstract][Full Text] [Related]
7. Prevention of cholesteryl ester accumulation in P388D1 macrophage-like cells by increased cellular vitamin E depends on species of extracellular cholesterol. Conventional heterologous non-human cell cultures are poor models of human atherosclerotic foam cell formation. Asmis R; Llorente VC; Gey KF Eur J Biochem; 1995 Oct; 233(1):171-8. PubMed ID: 7588742 [TBL] [Abstract][Full Text] [Related]
8. Impaired resistance to oxidation of low density lipoprotein in cystic fibrosis: improvement during vitamin E supplementation. Winklhofer-Roob BM; Ziouzenkova O; Puhl H; Ellemunter H; Greiner P; Müller G; van't Hof MA; Esterbauer H; Shmerling DH Free Radic Biol Med; 1995 Dec; 19(6):725-33. PubMed ID: 8582644 [TBL] [Abstract][Full Text] [Related]
9. Comparison of LDL trap assay to other tests of antioxidant capacity; effect of vitamin E and lovastatin treatment. Malminiemi K; Palomäki A; Malminiemi O Free Radic Res; 2000 Nov; 33(5):581-93. PubMed ID: 11200090 [TBL] [Abstract][Full Text] [Related]
10. Role of vitamin E in preventing the oxidation of low-density lipoprotein. Esterbauer H; Dieber-Rotheneder M; Striegl G; Waeg G Am J Clin Nutr; 1991 Jan; 53(1 Suppl):314S-321S. PubMed ID: 1985404 [TBL] [Abstract][Full Text] [Related]
11. Effect of antioxidants on oxidative modification of LDL. Esterbauer H; Puhl H; Dieber-Rotheneder M; Waeg G; Rabl H Ann Med; 1991; 23(5):573-81. PubMed ID: 1756027 [TBL] [Abstract][Full Text] [Related]
12. Differing effects of probucol and vitamin E on the oxidation of lipoproteins, ceroid accumulation and protein uptake by macrophages. Hunt JV; Bottoms MA; Taylor SE; Lyell V; Mitchinson MJ Free Radic Res; 1994 Mar; 20(3):189-201. PubMed ID: 8019642 [TBL] [Abstract][Full Text] [Related]
13. Predisposition to LDL oxidation during copper-catalyzed oxidative modification and its relation to alpha-tocopherol content in humans. Cominacini L; Garbin U; Cenci B; Davoli A; Pasini C; Ratti E; Gaviraghi G; Lo Cascio V; Pastorino AM Clin Chim Acta; 1991 Dec; 204(1-3):57-68. PubMed ID: 1819474 [TBL] [Abstract][Full Text] [Related]
14. Comparison of supplementation of RRR-alpha-tocopherol and racemic alpha-tocopherol in humans. Effects on lipid levels and lipoprotein susceptibility to oxidation. Reaven PD; Witztum JL Arterioscler Thromb; 1993 Apr; 13(4):601-8. PubMed ID: 8466895 [TBL] [Abstract][Full Text] [Related]
15. Effects of lovastatin therapy on susceptibility of LDL to oxidation during alpha-tocopherol supplementation. Palomäki A; Malminiemi K; Malminiemi O; Solakivi T Arterioscler Thromb Vasc Biol; 1999 Jun; 19(6):1541-8. PubMed ID: 10364087 [TBL] [Abstract][Full Text] [Related]
16. A critical overview of the chemistry of copper-dependent low density lipoprotein oxidation: roles of lipid hydroperoxides, alpha-tocopherol, thiols, and ceruloplasmin. Burkitt MJ Arch Biochem Biophys; 2001 Oct; 394(1):117-35. PubMed ID: 11566034 [TBL] [Abstract][Full Text] [Related]
17. Vitamin E, LDL, and endothelium. Brief oral vitamin supplementation prevents oxidized LDL-mediated vascular injury in vitro. Belcher JD; Balla J; Balla G; Jacobs DR; Gross M; Jacob HS; Vercellotti GM Arterioscler Thromb; 1993 Dec; 13(12):1779-89. PubMed ID: 8241098 [TBL] [Abstract][Full Text] [Related]
18. A randomized, single-blind, placebo-controlled trial of the effects of 200 mg alpha-tocopherol on the oxidation resistance of atherogenic lipoproteins. Porkkala-Sarataho EK; Nyyssönen MK; Kaikkonen JE; Poulsen HE; Hayn EM; Salonen RM; Salonen JT Am J Clin Nutr; 1998 Nov; 68(5):1034-41. PubMed ID: 9808219 [TBL] [Abstract][Full Text] [Related]
19. Impact of LDL carotenoid and alpha-tocopherol content on LDL oxidation by endothelial cells in culture. Dugas TR; Morel DW; Harrison EH J Lipid Res; 1998 May; 39(5):999-1007. PubMed ID: 9610766 [TBL] [Abstract][Full Text] [Related]
20. Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does alpha-tocopherol. Stocker R; Bowry VW; Frei B Proc Natl Acad Sci U S A; 1991 Mar; 88(5):1646-50. PubMed ID: 2000375 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]